Related Experiment Video
Updated: Oct 3, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Targeting CCL2-CCR4 axis suppress cell migration of head and neck squamous cell carcinoma
Zihang Ling1,2, Wei Li1,2, Jiaqi Hu1,2
1Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, 510055, P. R. China.
Abstract:
For head and neck squamous cell carcinoma (HNSCC), the local invasion and distant metastasis represent the predominant causes of mortality. Targeted inhibition of chemokines and their receptors is an ongoing antitumor strategy established on the crucial roles of chemokines in cancer invasion and metastasis. Herein, we showed that C-C motif chemokine ligand 2 (CCL2)- C-C motif chemokine receptor 4 (CCR4) signaling, but not the CCL2- C-C motif chemokine receptor 2 (CCR2) axis, induces the formation of the vav guanine nucleotide exchange factor 2 (Vav2)- Rac family small GTPase 1 (Rac1) complex to activate the phosphorylation of myosin light chain (MLC), which is involved in the regulation of cell motility and cancer metastasis. We identified that targeting CCR4 could effectively interrupt the activation of HNSCC invasion and metastasis induced by CCL2 without the promoting cancer relapse observed during the subsequent withdrawal period. All current findings suggested that CCL2-CCR4-Vav2-Rac1-p-MLC signaling plays an essential role in cell migration and cancer metastasis of HNSCC, and CCR4 may serve as a new potential molecular target for HNSCC therapy.
Insights
Targeting C-C motif chemokine ligand 2 (CCL2) and C-C motif chemokine receptor 4 (CCR4) signaling inhibits head and neck squamous cell carcinoma (HNSCC) metastasis. This pathway, involving Vav2-Rac1-p-MLC, offers a potential therapeutic target for HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Head and neck squamous cell carcinoma (HNSCC) mortality is primarily driven by local invasion and distant metastasis.
- Chemokines and their receptors are critical regulators of cancer cell migration and metastasis, making them attractive therapeutic targets.
Purpose of the Study:
- To investigate the role of C-C motif chemokine ligand 2 (CCL2) signaling pathways in HNSCC invasion and metastasis.
- To identify potential molecular targets for interrupting HNSCC metastasis.
Main Methods:
- Analysis of the CCL2-C-C motif chemokine receptor 4 (CCR4) and CCL2-C-C motif chemokine receptor 2 (CCR2) signaling axes.
- Investigation of the formation of the vav guanine nucleotide exchange factor 2 (Vav2)-Rac family small GTPase 1 (Rac1) complex.
- Assessment of myosin light chain (MLC) phosphorylation as a downstream effect.
Main Results:
- The CCL2-CCR4 axis, not CCL2-CCR2, induced Vav2-Rac1 complex formation and subsequent MLC phosphorylation.
- Targeting CCR4 effectively inhibited CCL2-induced HNSCC invasion and metastasis.
- No cancer relapse was observed after CCR4 inhibition withdrawal.
Conclusions:
- The CCL2-CCR4-Vav2-Rac1-p-MLC signaling pathway is crucial for HNSCC cell migration and metastasis.
- CCR4 represents a promising molecular target for HNSCC therapy, potentially offering a durable therapeutic effect without promoting relapse.
More Related Videos
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Cytoskeletal Coordination in Cell Migration
Cell Migration
Cancer Cell Migration through Invadopodia
Cell Polarization by Rho Proteins
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....

